Liminal BioSciences : Notice of Special Meeting of Shareholders and Management Information Circular dated August 16, 2023 - Form 6-K -Today at 06:08 am

)













...

Related Keywords

Canada ,Ontario ,Montreal ,Quebec ,Ottawa ,Fairhaven ,Newfoundland ,District Of Columbia ,United States ,Province Of Ontario ,Cayman Islands ,Toronto ,Cambridge ,Cambridgeshire ,United Kingdom ,Sawston ,America ,American ,Canadian ,Garyj Bridger ,Zealand Pharma ,Julien Robitaille Rodriguez ,Nicole Rusaw ,Neila Klompas ,Neila Komplas ,Basilea Pharmaceutica ,John Emanoilidis ,Sadam Ibrahim ,Xenetic Biosciences ,Bruce Pritchard ,Patrick Sartore ,Justice Cour ,Andrew Gray ,Timothy Steven Wach ,Stikeman Elliott ,Alek Krstajic ,Timothys Wach ,Marie Iskra ,Eugene Siklos ,Pierre Yves Leduc ,Simon Best ,Cincor Pharma ,Eli Lilly ,N Nicole Rusaw ,Zev Smith ,Forte Biosciences ,Peterj Thomson ,Piper Sandler ,Stikeman Elliot ,Hillstream Biopharma ,Thomson Reuters Corporation ,Amorchem Limited Partnership ,Stock Exchange Delisting ,Company The Defendants ,Procedure For Exchange Of Share Certificates ,Point Therapeutics Inc ,Covenants Of The Company ,Computershare Trust Company Of Canada ,Toronto Stock Exchange ,Alexion Pharmaceuticals ,Company Under Section ,Bilodeauv Liminal Biosciences Inc ,Officers Of The Company ,Carson Proxy Advisors The Company ,Development Canada ,Nesbitt Burns Inc ,Celator Pharmaceuticals ,International Financial Reporting Standards ,Company Annual Report On Form ,Merck Co ,Canada Revenue Agency ,Company Certificate ,Company Meeting ,Board Of The Company ,Toronto Superior Court ,Company Report On Form ,Canadian Investment Regulatory Organization ,Langstaff Co ,Shareholders Of The Company ,Recommendation Of The Special Committee ,Ontario Superior Court ,Administration Expenses ,Court File No ,Company Circularfor ,Management Of The Company ,Third Party As ,Obligations Of The Company ,Court Under Section ,Rule Of The Company ,Comera Life Sciences Holdings ,Agonist Program ,Nasdaq Stock Market ,Computershare Investor Services Inc ,Company Historical Financial Information ,Company Shareholder ,United States Securities Exchange ,Us Exchange ,Purchaser Filing Party ,Pharmaceuticals Inc ,Development Expenses ,Arrangement For The Company ,Imago Biosciences Inc ,Nuvo Pharmaceuticals Inc ,Exchange Commission ,Q Does The Special Committee ,Montreal The Bank ,Company Or Liminal Biosciences ,Company Annual Report Form ,Merrimack Pharmaceuticals ,Company Disclosure Letter ,Company Information ,Aquinox Pharmaceuticals Inc ,Lawyers For Liminal Biosciences Inc ,Salarius Pharmaceuticals ,Innovon Life Sciences Holdings ,Revenue Service ,Material Change Report Of The Company ,Meeting Materials Or Court ,Company Nols ,Court Approval ,Company Stock Option Plan ,Company Warrantsand Rsusunder The Arrangement ,Company Options ,Commitment To Acquire Securities Of The Company ,Court Materials ,Antagonist Program ,Gilead Sciences ,Foreign Investment Company Consequences ,Valorisation Inc ,Amgen ,Company The Certificate ,Party Or ,Zymeworks Inc ,Securities Authority ,Affairs Of The Company ,Achillion Pharmaceuticals ,Foreign Investment Company ,Covenants Relating To Exchange Delisting ,Court Materials As Liminal ,Xenon Pharmaceuticals ,Company Unaffiliated Securityholders ,Companya Dissent Notice ,Board Of Liminal Biosciences Inc ,Summary Of The Company Cash ,Bristol Myers Squibb Company ,Thomvest Asset Management Inc ,Exchange Or Other Disposition ,Capital Corp ,Company Financial ,Summary Of The Company Outstanding Securities ,Party Transactions ,Prometic Life Sciences Inc On ,Shareholder Of The Company ,Liminal Biosciences Inc On ,Commitments To Acquire Securities Of The Company ,International Accounting Standards Board ,Development Of The Company ,Justice Commercial List The Court ,Company The ,Compensation Of The Special Committee ,Checkmate Pharmaceuticals ,Possibility For The Company ,Ionic Brands Corp ,Astrazeneca ,Company Shareholders ,Commerce Court ,Clinical Development Success ,Parliament Of Canada ,Arrangement For The Company Minority Shareholders ,Committee Approval ,Fairhaven Pharmaceuticals Inc ,Court On ,Information Technology ,None Of The Company ,Regeneron Pharmaceuticals ,Subsidiaries Of The Company ,Company Employee ,Pfizer ,Biotechnology Innovation Organization ,Liminal Biosciences Inc ,Company Minority Shareholders ,Subsidiary Of The Company ,Nasdaq ,National Instrument ,Nabis Holdings Inc ,Shareholders Of The Company Meeting ,Thomvest Asset Management Ltd ,Company Name ,Company The Confidentiality Agreement ,Order Of The Ontario Superior Court ,Committee On ,Committee Of The Board Directors ,Liminal Biosciences ,Carson Proxy Advisors ,North American ,North America ,Special Meeting ,Recusing Directors ,Special Committee ,Commercial List ,Structured Alpha ,Canada Business Corporations ,Minority Shares ,Arrangement Agreement ,Minority Shareholders ,Multilateral Instrument ,Special Transactions ,Arrangement Resolution ,Liminal Bioscience ,Computershare Trust Company ,Business Days ,Interim Order ,Canada Business Corporations Act ,Record Date ,Minority Security Holders ,Excluded Shares ,Dissent Rights ,Dissent Notice ,General Counsel ,Frappier Boulevard ,Boulevard West ,Street West ,Trust Company ,Bourassa Boulevard ,Proxy Department ,Business Day ,Shareholder Dissent Rights ,Regulatory Matters ,Management Information Circular ,Carson Proxy Advisor ,Canadian Securities Laws ,Nasdaq Listing Rule ,Nasdaq Capital Market ,Annual Report ,Frappier Blvd ,United States Securities Exchange Act ,Purchaser Filing Parties ,Answers About ,Voting Agreements ,Final Order ,Effective Date ,Required Shareholder Approval ,Minority Shareholder ,Effective Time ,Share Certificates ,Material Adverse Effect ,Termination Fee ,Voting Information ,Dissenting Shareholders ,Registered Shareholders ,Bourassa Blvd ,Non Registered Shareholders ,Third Party ,Canadian Federal Income Tax ,President Holder ,Dissenting Resident Holder ,Non Resident Holder ,Dissenting Non Resident Holder ,United States Federal Income Tax ,Are Shareholders ,Voting Shares ,Principal Holders ,Street East ,Eastern Time ,Outside Date ,Formal Valuation ,Special Committees ,Independent Financial Advisor ,Purchaser Filing Partie Purpose ,Purchaser Filing Partie Purposes ,Purchaser Filing Partie Position ,Certain Persons ,Dissenting Shareholder ,Investor Services ,Chief Executive Officer ,Review Process ,Companion Policy ,Chief Financial Officer ,Revised Proposal ,Biosciences Purpose ,Minority Share ,Regulatory Approvals ,Likely Prospect ,Competing Alternative ,Countervailing Factors Inherent ,Material Adverse ,Factors The Arrangement Reasons ,Fair Market Value ,Fair Market ,Selected Precedent ,Committee Update ,Discussion Materials ,Company Warrants ,Purchaser Filings Parties ,Unaffiliated Securityholders ,Acquisition Proposal ,Purchaser Filing ,Exchange Delisting ,Reporting Issuer ,Income Tax ,Concerning Liminal Biosciences ,Company Option ,Control Benefits ,Regarding Insurance ,Constating Documents ,Executive Officers ,Security Holders ,Liminal Bioscience Shareholder ,Google Chrome ,Internet Explorer ,Microsoft Edge ,Registered Shareholder ,Share Certificate ,Securities Laws ,Instruction Form ,Minority Approval ,Subject Securities ,Voting Agreement ,Omnibus Incentive Plan ,Company Warrant ,Fairhaven Second Milestone Share Entitlement ,Fairhaven Vendors ,Dissenting Holders ,Dissenting Holder ,Non Registered Minority Shareholders ,Tax Act ,Financial Advisory ,Company Regarding ,Governmental Entity ,Pre Acquisition Reorganization ,Ordinary Course ,Permitted Liens ,Tax Return ,Company Employees ,Employee Plan ,Material Contract ,Intellectual Property ,Tax Returns ,Pre Acquisitions Reorganizations ,Company Relating ,Governmental Entities ,Purchaser Relating ,Material Contracts ,Regarding Access ,Confidentiality Agreement ,Exchange Act ,Post Closing Employment Matters ,Covered Employee ,Company Disclosure ,Covered Employees ,Employee Plans ,Material Undisclosed ,Certain Changes ,Required Vote ,Conditions Precedent ,Superior Proposal ,Subsidiaries Representatives ,Match Period ,Board Recommendation ,New Brunswick ,Reporting Issuer Status ,Dissent Shares ,Investor Services Inc ,Payment Demand ,Transfer Agent ,Dissent Right ,Dissenting Shareholders Shares ,Purchaser Filing Person ,Life Sciences Inc ,Biosciences Inc ,Nasdaq Global Market ,Nasdaq Capital ,Acquire Securities ,Chief Legal Officer ,Corporate Secretary ,Road Capital ,Chief Operating Officer ,Ground Floor ,Iconix Park ,London Road ,Black Scholes ,Fairhaven Pharmaceuticals ,Comprehensive Income ,Cash Flows ,Material Change Report ,Form Prospectus ,Tax Proposals ,Canada Revenue ,Certain Resident Holders ,Canadian Federal Income Tax Considerations ,Resident Holders ,Capital Losses ,Not Resident ,Non Resident Holders ,Revenue Code ,Internal Revenue Service ,Backup Withholding ,Securities Class Actions ,Oppression Claims ,Derivative Lawsuits Which Could Result ,May Delay ,Being Completed ,Securities Act ,Canadian Depository ,Canadian Investment Regulatory ,Internal Revenue Code ,Stock Option ,Thomvest Asset Management ,Computershare Investor Services ,Direct Registration System ,Electronic Data Gathering ,United States Securities Act ,Canada Pension Plan ,Pension Plan ,Second Milestone Share ,Royal Institution ,Mcgill University ,Genesys Ventures ,International Accounting Standards ,Leased Real Property ,Securities Authorities ,Beneficial Owners ,Financial Statements ,Omnibus Incentive ,Oxley Act ,Electronic Document Analysis ,Income Tax Act ,Toronto Stock ,Sarbanes Oxley Act ,Common Shares ,Common Share ,Fairhaven Covenants ,Company Warrantsand ,Superior Court ,Klompas Affidavit ,Information Circular ,Meeting Materials ,Additional Information ,Canadian Securities Regulatory Authorities ,Court West ,Electronic Commerce Protection Regulations ,Civil Procedure ,Application Record ,Liminal Shares ,Liminal Share ,Share Purchase Agreement ,Genesys Ventures Ill ,Engagement Agreement ,Refinancing Litigation ,Outstanding Securities ,Stock Options Issued ,Average Exercise Price ,Average Years ,Warrants Issued ,Ended December ,Continuing Operations Before Taxes ,Evaluation Methodologies ,Lucy Scientific Discovery ,Point Therapeutics ,Modelled Business ,Modelled Busines ,Clinical Development Success Rates ,Contributing Factors ,Informal Pharma Intelligence ,Financial Forecast ,Kroll Valuation Handbook ,Forecast Period ,Discounted Cash Flow ,Average Cost ,Unlevered Free Cash Flows ,Terminal Value ,Earlier Stage Programs ,Public Filings ,Equity Value ,Ownership Dilution ,Unaffected Date ,American Toll Free Phone ,Markets ,